Andrew Witty
See the following -
Across Pharma, Few Open Arms For Trial Data Sharing
Alex Philippidis | Genetic Engineering & Biotechnology News (GEN) | July 9, 2013
Industry inches toward consensus on limited sharing as EMA, GSK press for open access. Read More »
- Login to post comments
GSK Expands Open-Source Research Project In TB
Staff Writer | PMLIVE | October 11, 2012
GlaxoSmithKline (GSK) has screened its entire pharmaceutical compound library of more two million compounds and identified about 200 hits with potential against tuberculosis (TB), which it will make available to external research teams as part of its drive towards an 'open innovation' approach to R&D. Read More »
- Login to post comments